Aerpio Pharmaceuticals Inc. (ARPO): Current Recommendation for ARPO is 3.00


Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) changes shares on Tuesday trading session, with a change of 2.33% or $0.03 shares. The trading starts at $1.29 and closed at $1.29 throughout the day. The trading session low price was $1.26 and day high was $1.321 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 5.82 million while its average volume is 2.49M. In other hand, the ARPO market cap reached to $54.91M.

On June 25, 2020, BRIEF-Aerpio Pharmaceuticals Says On June 11 It Got Notice From Nasdaq Of Regaining Compliance. According to the news reported on Reuters, * AERPIO PHARMACEUTICALS – ON JUNE 11, CO GOT NOTICE FROM NASDAQ OF REGAINING COMPLIANCE Source text: [ID:] Further company coverage:

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -1.49% and up 3.13% for month. Its quarterly performance was 112.90% above, while its half year performance is up 90.23%. ARPO yearly performance stood at positive 78.86% and rise 111.71% for year-to-date. Current recommendation for Aerpio Pharmaceuticals Inc. is 3.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ARPO EPS (TTM) for 12-month is -0.46. Its EPS Q/Q reached 53.90%.

Let’s take a look on the analyst recommendations on ARPO for the current month and previous month. For the current month, 0 of 1 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.50 – $1.50. Average target price for ARPO was reached at $1.50.

Orbimed Advisors LLC., Vanguard Group, Inc. (The) and Renaissance Technologies, LLC are the top three holders in Aerpio Pharmaceuticals Inc. (ARPO) stock. On Mar 30, 2020, Orbimed Advisors LLC. has 5.19 million shares which valued 2.86 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 1.19 million shares which valued at 0.66 million. On Mar 30, 2020, Renaissance Technologies, LLC has a total of 0.45 million shares which valued at 0.25 million. In the end, Renaissance Technologies, LLC have 1.11% shares outstanding of Aerpio Pharmaceuticals Inc. (ARPO) on Mar 30, 2020. The insider ownership moved to 24.32% and institutional holding shifted to 24.50%.

The company posted an EPS (TTM) of -0.46. Comparing with last year, the average estimated EPS was -0.21 which is lower than -0.11 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ARPO rise 73.30% for period of 200 days. SMA for 50 days was 6.01% which is showing green signal, while SMA-20 was -1.99%. The moving average value for Aerpio Pharmaceuticals Inc. (ARPO) is 83.46k and 0.16% for 200 and 50 days respectively.